Starting at 5 mg instead of 2.5 mg Some providers start patients at 5 mg when: The patient was on maximum-dose semaglutide (2.0 to 2.4 mg) for 6 or more months with good tolerance The patient experienced no significant GI side effects on semaglutide Weight loss has been stalled for 8 or more weeks despite medication compliance The patient has a BMI above 40 and more aggressive weight loss is clinically appropriate A study examining GLP-1 to tirzepatide transitions found that patients who started at 5 mg had manageable side effects and comparable outcomes to those who started at 2.5 mg, provided they had prior GLP-1 experience
Schedule a consultation with You Holistic to explore how Glutathione therapy can benefit you
Discuss any right upper quadrant pain, nausea after fatty meals, or abdominal bloating with your provider immediatelythese may signal gallbladder distress
Pink (rose, salmon): typically B12 at 0.5 to 1.0 mg/mL
Specifically, retatrutide targets the following receptors: GLP-1 (glucagon-like peptide-1) GIP (glucose-dependent insulinotropic polypeptide) Glucagon These hormones help regulate hunger, blood sugar and energy use
We offer both brand name medications and compounded semaglutide and tirzepatide options when medically necessary, ensuring your plan is tailored to your unique needs